Be on the lookout for a price bounce soon.
The Moving Average Convergence Divergence (MACD) for BYNOU just turned positive on January 02, 2025. Looking at past instances where BYNOU's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 86 cases where BYNOU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for BYNOU moved out of overbought territory on January 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (156.177). P/E Ratio (0.000) is within average values for comparable stocks, (144.064). Dividend Yield (0.000) settles around the average of (0.056) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (202.075).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BYNOU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYNOU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
Industry FinancialConglomerates
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JMNSX | 15.66 | -0.03 | -0.19% |
JPMorgan Research Market Neutral I | |||
FKIDX | 14.15 | -0.20 | -1.39% |
Fidelity Diversified Intl K6 | |||
FMIEX | 8.94 | -0.13 | -1.43% |
Wasatch Global Value Investor | |||
DBMAX | 27.56 | -0.43 | -1.54% |
BNY Mellon Sm/Md Cp Gr A | |||
MSVOX | 5.96 | -0.11 | -1.81% |
Morgan Stanley Vitality Portfolio R6 |
A.I.dvisor indicates that over the last year, BYNOU has been closely correlated with RRACF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BYNOU jumps, then RRACF could also see price increases.
Ticker / NAME | Correlation To BYNOU | 1D Price Change % | ||
---|---|---|---|---|
BYNOU | 100% | N/A | ||
RRACF - BYNOU | 66% Closely correlated | N/A | ||
IVCAU - BYNOU | 60% Loosely correlated | -0.33% | ||
WELNF - BYNOU | 48% Loosely correlated | N/A | ||
MITAU - BYNOU | 43% Loosely correlated | N/A | ||
BRAC - BYNOU | 35% Loosely correlated | +2.38% | ||
More |
Ticker / NAME | Correlation To BYNOU | 1D Price Change % |
---|---|---|
BYNOU | 100% | N/A |
Financial Conglomerates industry (234 stocks) | -12% Poorly correlated | -0.32% |